GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹1,269 Cr | ₹1,333 Cr | ₹1,025 Cr | ₹1,510 Cr | ₹1,302 Cr |
What is the latest Operating Profit of GLAND PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹1,269 Cr |
| Mar2025 | ₹1,333 Cr |
| Mar2024 | ₹1,025 Cr |
| Mar2023 | ₹1,510 Cr |
| Mar2022 | ₹1,302 Cr |
How is Operating Profit of GLAND PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,269 Cr | -4.81 | |
| Mar2025 | ₹1,333 Cr | 30.09 | |
| Mar2024 | ₹1,025 Cr | -32.14 | |
| Mar2023 | ₹1,510 Cr | 15.97 | |
| Mar2022 | ₹1,302 Cr | - | |
Compare Operating Profit of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹54,967.3 Cr | -1.4% | 16.5% | 81.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -1.4% |
16.5% |
81.4% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses